Changes in routine laboratory tests and survival in amyotrophic lateral sclerosis
- 4 October 2017
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 38 (12) , 2177-2182
Abstract
The aim of this study is to evaluate the association between changes in routinely prescribed laboratory tests and tracheostomy-free survival in amyotrophic lateral sclerosis (ALS). Two hundred seventy-five ALS patients were retrospectively studied. BMI, forced vital capacity, hemoglobin, hematocrit, lymphocytes, cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, proteins, albumin, creatine-phosphokinase, iron, ferritin, transferrin, glucose, urea, uric acid, and creatinine were measured every 6 months from baseline to 24 months, death or study end, together with the probability of death or tracheostomy. Missing data were handled using multiple imputation chained equations. Hemoglobin (OR = 1.71, 95%CI 1.24–2.36 for IQR increase), hematocrit (OR = 1.87, 95%CI 1.34–2.63 for IQR increase), urea (OR = 1.51, 95%CI 1.21–1.89 for IQR increase), and uric acid (OR = 1.98, 95%CI 1.23–3.20 for IQR increase) were directly associated, while triglycerides (OR = 0.69, 0.51 to 0.93 for IQR increase) were inversely associated with the odds of death or tracheostomy. In our cohort, an increase of hemoglobin, hematocrit, urea, and uric acid was directly associated, and an increase of triglycerides was inversely associated with the odds of death or tracheostomy. Should these findings be replicated in an external cohort, they might help to discriminate ALS progression and patients’ decisions about procedures and end of life.Keywords
This publication has 34 references indexed in Scilit:
- Factors predicting survival in ALS: a multicenter Italian studyJournal of Neurology, 2016
- Prognostic factors for the course of functional status of patients with ALS: a systematic reviewJournal of Neurology, 2014
- Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and CreatinineJAMA Neurology, 2014
- Iron Metabolism Disturbance in a French Cohort of ALS PatientsBioMed Research International, 2014
- Elevated Serum Ferritin Is Associated with Reduced Survival in Amyotrophic Lateral SclerosisPLOS ONE, 2012
- Clinical diagnosis and management of amyotrophic lateral sclerosisNature Reviews Neurology, 2011
- Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosisJournal of Neurology, 2010
- Do serum uric acid levels reflect oxidative stress in the progression of ALS?Journal of the Neurological Sciences, 2009
- Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?Journal of the Neurological Sciences, 2009
- Dyslipidemia is a protective factor in amyotrophic lateral sclerosisNeurology, 2008